| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827036 | Transplantation Proceedings | 2018 | 6 Pages |
Abstract
All 3 agents had similar rates of early allograft dysfunction and renal dysfunction. Subgroup analysis of high-risk donor grafts showed no statistical difference. In conclusion, administration of desflurane or sevoflurane may provide some early hepatoprotection against IRI, but longer-term outcomes were equivalent for all agents.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
R.S. Mangus, S.B. Kinsella, D.T. Farar, J.A. Fridell, L.T. Woolf, C.A. Kubal,